Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell as Therapeutic Modality in Interstitial Pulmonary Fibrosis

NCT03187431 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT03187431
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03187431 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell as Therapeutic Modality in Interstitial Pulmonary Fibrosis
Lead sponsor
Assiut University
Phase
Phase 1
Overall status
Unknown status
Start date
December 11, 2017
Completion date
December 1, 2018
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

stem cell transplant complications